BRCA and pancreatic cancer.
Gregory T Brennan1, Valerie Relias, Muhammad Wasif Saif
1Division of GI Oncology and Experimental Therapeutics, Tufts Medical Center. Boston, MA 02111, USA.
JOP : Journal of the Pancreas
|July 13, 2013
Summary
Germline BRCA mutations are linked to pancreatic cancer. Patients with these mutations may benefit from chemotherapy combined with poly(ADP-ribose) polymerase inhibitors (PARPi), according to recent data.
Area of Science:
- Oncology
- Genetics
- Pharmacology
Background:
- Germline mutations in BRCA genes are recognized risk factors for developing pancreatic cancer.
- Emerging evidence suggests a potential therapeutic advantage for patients with BRCA mutations when treated with specific drug combinations.
Purpose of the Study:
- To review recent clinical data on the efficacy of poly(ADP-ribose) polymerase inhibitors (PARPi) in combination with conventional chemotherapy for pancreatic cancer patients with germline BRCA mutations.
- To highlight findings presented at the 2013 American Society of Clinical Oncology (ASCO) Annual Meeting relevant to this patient population.
Main Methods:
- Review of abstracts presented at the 2013 ASCO Annual Meeting (Abstracts #11024 and #TPS4144).
- Analysis of laboratory and clinical data associating BRCA mutations with pancreatic cancer and treatment response.
Main Results:
- Preliminary data suggest that pancreatic cancer patients harboring germline BRCA mutations may exhibit enhanced sensitivity to treatment regimens incorporating PARPi.
- Specific abstracts presented at ASCO 2013 provide updated insights into this therapeutic approach.
Conclusions:
- Patients with germline BRCA mutations represent a distinct subgroup in pancreatic cancer that may respond favorably to PARPi-based chemotherapy.
- Further investigation and clinical trials are warranted to confirm the efficacy and optimize the use of PARPi in this setting.
Related Concept Videos
01:25Chronic Pancreatitis I: Introduction
Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
01:24Chronic Pancreatitis I: Introduction
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:21Chronic Pancreatitis II: Pathophysiology
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...